AI assistant
Sending…
Avidity Biosciences, Inc. — Director's Dealing 2020
Jul 27, 2020
30894_dirs_2020-07-27_0df393b6-896f-4419-9d7f-d6feaddd2727.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2020-07-27
Reporting Person: Kim Jae B. (Chief Medical Officer)
More from Avidity Biosciences, Inc.
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27